KYTX — Kyverna Therapeutics, Inc. stock price, charts and financials

QT82Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc. (NASDAQ: KYTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
7.89
-0.07-0.88%
OverviewShort InterestFilings
KYTXQT82Kyverna Therapeutics, Inc.·NASDAQ
7.89-0.88%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 27, 20268-KCurrent report
Jul 09, 20268-KCurrent report
Jun 02, 20268-KCurrent report
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20263Initial statement of beneficial ownership
May 18, 20268-KCurrent report
May 12, 202610-QQuarterly report
May 12, 20268-KCurrent report
May 06, 20263Initial statement of beneficial ownership
May 06, 20264Statement of changes in beneficial ownership
May 04, 20268-KCurrent report
Apr 22, 20268-KCurrent report
Apr 22, 20268-KCurrent report
Apr 20, 20268-KCurrent report
Apr 13, 2026ARSAnnual report to shareholders
Apr 13, 2026DEF 14ADefinitive proxy statement
Apr 13, 2026DEFA14AAdditional proxy soliciting materials
Apr 02, 2026424B5Prospectus
Apr 02, 2026EFFECTNotice of effectiveness
#1 / 25 of 173
Page
▼
/ 7